135 related articles for article (PubMed ID: 23643138)
21. Dietary advanced glycation end products and their role in health and disease.
Uribarri J; del Castillo MD; de la Maza MP; Filip R; Gugliucci A; Luevano-Contreras C; Macías-Cervantes MH; Markowicz Bastos DH; Medrano A; Menini T; Portero-Otin M; Rojas A; Sampaio GR; Wrobel K; Wrobel K; Garay-Sevilla ME
Adv Nutr; 2015 Jul; 6(4):461-73. PubMed ID: 26178030
[TBL] [Abstract][Full Text] [Related]
22. Effects of Weight Loss on Advanced Glycation End Products in Subjects with and without Diabetes: A Preliminary Report.
Deo P; Keogh JB; Price NJ; Clifton PM
Int J Environ Res Public Health; 2017 Dec; 14(12):. PubMed ID: 29232895
[TBL] [Abstract][Full Text] [Related]
23. Dietary intake of advanced glycation endproducts is associated with higher levels of advanced glycation endproducts in plasma and urine: The CODAM study.
Scheijen JLJM; Hanssen NMJ; van Greevenbroek MM; Van der Kallen CJ; Feskens EJM; Stehouwer CDA; Schalkwijk CG
Clin Nutr; 2018 Jun; 37(3):919-925. PubMed ID: 29381139
[TBL] [Abstract][Full Text] [Related]
24. Metabolic transit of dietary advanced glycation end-products - the case of N
Tessier FJ; Boulanger E; Howsam M
Glycoconj J; 2021 Jun; 38(3):311-317. PubMed ID: 32990827
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of a gas chromatography/mass spectrometry method for the quantification of carboxymethyllysine in food samples.
Charissou A; Ait-Ameur L; Birlouez-Aragon I
J Chromatogr A; 2007 Jan; 1140(1-2):189-94. PubMed ID: 17174315
[TBL] [Abstract][Full Text] [Related]
26. The advanced glycation end product N
Holik AK; Lieder B; Kretschy N; Somoza MM; Ley JP; Hans J; Somoza V
J Cell Biochem; 2018 Mar; 119(3):2731-2741. PubMed ID: 29052845
[TBL] [Abstract][Full Text] [Related]
27. Methylglyoxal-hydroimidazolones (MG-Hs) instead of Nɛ-(carboxymethyl)-l-lysine (CML) is the major advanced glycation end-product during drying process in black tea.
Zhang W; Zhang B; Ye Y; Zhu H
Food Chem; 2020 Dec; 333():127499. PubMed ID: 32673957
[TBL] [Abstract][Full Text] [Related]
28. Maillard reactions by alpha-oxoaldehydes: detection of glyoxal-modified proteins.
Sady C; Jiang CL; Chellan P; Madhun Z; Duve Y; Glomb MA; Nagaraj RH
Biochim Biophys Acta; 2000 Sep; 1481(2):255-64. PubMed ID: 11018716
[TBL] [Abstract][Full Text] [Related]
29. Dietary Advanced Glycation End-Products (dAGEs) Intake and Bone Health: A Cross-Sectional Analysis in the Rotterdam Study.
Waqas K; Chen J; van der Eerden BCJ; Ikram MA; Uitterlinden AG; Voortman T; Zillikens MC
Nutrients; 2020 Aug; 12(8):. PubMed ID: 32784487
[TBL] [Abstract][Full Text] [Related]
30. Immunological evidence that non-carboxymethyllysine advanced glycation end-products are produced from short chain sugars and dicarbonyl compounds in vivo.
Takeuchi M; Makita Z; Bucala R; Suzuki T; Koike T; Kameda Y
Mol Med; 2000 Feb; 6(2):114-25. PubMed ID: 10859028
[TBL] [Abstract][Full Text] [Related]
31. Immunohistochemical localization of different epitopes of advanced glycation end products in human atherosclerotic lesions.
Sakata N; Imanaga Y; Meng J; Tachikawa Y; Takebayashi S; Nagai R; Horiuchi S; Itabe H; Takano T
Atherosclerosis; 1998 Nov; 141(1):61-75. PubMed ID: 9863539
[TBL] [Abstract][Full Text] [Related]
32. Advanced glycation end products in diabetic and non-diabetic human subjects suffering from cataract.
Hashim Z; Zarina S
Age (Dordr); 2011 Sep; 33(3):377-84. PubMed ID: 20842534
[TBL] [Abstract][Full Text] [Related]
33. Dietary consumption of meat, fat, animal products and advanced glycation end-products and the risk of Barrett's oesophagus.
Jiao L; Kramer JR; Chen L; Rugge M; Parente P; Verstovsek G; Alsarraj A; El-Serag HB
Aliment Pharmacol Ther; 2013 Oct; 38(7):817-24. PubMed ID: 23957669
[TBL] [Abstract][Full Text] [Related]
34. Advanced glycation end products in foods and a practical guide to their reduction in the diet.
Uribarri J; Woodruff S; Goodman S; Cai W; Chen X; Pyzik R; Yong A; Striker GE; Vlassara H
J Am Diet Assoc; 2010 Jun; 110(6):911-16.e12. PubMed ID: 20497781
[TBL] [Abstract][Full Text] [Related]
35. Advanced Glycation End Products and esRAGE Are Associated With Bone Turnover and Incidence of Hip Fracture in Older Men.
Lamb LS; Alfonso H; Norman PE; Davis TME; Forbes J; Müench G; Irrgang F; Almeida OP; Golledge J; Hankey GJ; Flicker L; Yeap BB
J Clin Endocrinol Metab; 2018 Nov; 103(11):4224-4231. PubMed ID: 30137355
[TBL] [Abstract][Full Text] [Related]
36. Immunohistochemical evidence for an increased oxidative stress and carbonyl modification of proteins in diabetic glomerular lesions.
Suzuki D; Miyata T; Saotome N; Horie K; Inagi R; Yasuda Y; Uchida K; Izuhara Y; Yagame M; Sakai H; Kurokawa K
J Am Soc Nephrol; 1999 Apr; 10(4):822-32. PubMed ID: 10203367
[TBL] [Abstract][Full Text] [Related]
37. Metabolization of the Advanced Glycation End Product N-ε-Carboxymethyllysine (CML) by Different Probiotic E. coli Strains.
Hellwig M; Auerbach C; Müller N; Samuel P; Kammann S; Beer F; Gunzer F; Henle T
J Agric Food Chem; 2019 Feb; 67(7):1963-1972. PubMed ID: 30701968
[TBL] [Abstract][Full Text] [Related]
38. Prediction of CML contents in the Maillard reaction products for casein-monosaccharides model.
Oh MJ; Kim Y; Hoon Lee S; Lee KW; Park HY
Food Chem; 2018 Nov; 267():271-276. PubMed ID: 29934167
[TBL] [Abstract][Full Text] [Related]
39. Detection of noncarboxymethyllysine and carboxymethyllysine advanced glycation end products (AGE) in serum of diabetic patients.
Takeuchi M; Makita Z; Yanagisawa K; Kameda Y; Koike T
Mol Med; 1999 Jun; 5(6):393-405. PubMed ID: 10415164
[TBL] [Abstract][Full Text] [Related]
40. Free advanced glycation end product distribution in blood components and the effect of genetic polymorphisms.
Nomi Y; Kudo H; Miyamoto K; Okura T; Yamamoto K; Shimohiro H; Kitao S; Ito Y; Egawa S; Kawahara K; Otsuka Y; Ueta E
Biochimie; 2020 Dec; 179():69-76. PubMed ID: 32946992
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
